Angle Health has raised $200M in Series C funding and $400M through a tender offer, a package that values the insurtech at $2.7B. For a company founded in 2019 that does not sell AI agents, a raise that size is unusual.
Vitruvian Partners led the round. Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital and Y Combinator also took part.
Employee liquidity is part of the deal. The tender lets staff cash out a portion of their holdings, and the company’s guidance is that closing happens within the month.
Angle’s Y Combinator batch was winter 2020. It sells small businesses level-funded health coverage and administers those plans for them.
Two familiar models frame the product. In fully insured coverage the carrier carries the risk, which buys predictability at a higher price. Under a self-funded plan the employer settles the claims itself, so the bill can move against it. Level-funded plans sit between those poles: the employer pays the carrier a fixed premium, the carrier absorbs claims that come in above expectations, and money left over when claims run low can be returned as a surplus share.
Behind that sits software. Angle runs an AI-powered platform wired into payroll and HR systems that helps employers pick plans and then run them day to day, and it argues the model makes coverage more affordable for small firms. The company reports profitability, with a customer base above 5,000 businesses.
The takeaway for founders: revenue-generating software aimed at one industry can still command capital even while the market’s attention sits on AI infrastructure and agent startups.
